2 Upcoming FDA Approval Decisions That Investors Should Really Watch
Few things are more important to drugmakers than winning regulatory approvals for new products. In this Motley Fool Live video recorded on Oct. 13, Fool contributors Keith Speights and Brian Orelli discuss two upcoming U.S. Food and Drug Administration (FDA) approval decisions that investors should keep an eye on.
Source Fool.com